Jul 13, 2026 02:29PM
Jun 23, 2026 04:11PM
Mar 10, 2026 12:08PM
Feb 25, 2026 02:27PM
Feb 25, 2026 06:22AM
Feb 24, 2026 04:45PM
Jan 23, 2026 07:19AM Vaxcyte (PCVX) Reiterated at Overweight by Cantor Fitzgerald: Next Catalyst in 4Q26
Jan 6, 2026 08:18AM
Dec 21, 2025 08:00PM
Dec 9, 2025 04:40AM
Nov 19, 2025 05:23AM
Nov 4, 2025 05:54PM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
Sep 30, 2025 08:35AM
Sep 12, 2025 05:54AM
Aug 8, 2025 08:34AM
Aug 6, 2025 06:22PM
Jun 10, 2025 06:56AM
May 8, 2025 06:22AM
May 1, 2025 08:01AM Vaxcyte, Inc (PCVX) Appoints Olivier Brandicourt to its Board
Apr 22, 2025 07:22AM
Apr 1, 2025 05:07AM
Mar 31, 2025 10:04AM
Mar 31, 2025 08:05AM
Mar 31, 2025 07:00AM
Mar 3, 2025 01:28PM
Feb 24, 2025 05:04AM BTIG Reiterates Buy Rating on Vaxcyte (PCVX)
Feb 17, 2025 05:38PM
Feb 5, 2025 08:02AM
Dec 20, 2024 06:19AM
Dec 19, 2024 02:00PM
Nov 12, 2024 07:31AM
Nov 6, 2024 06:13AM
Nov 6, 2024 05:59AM Leerink Partners Reiterates Outperform Rating on Vaxcyte (PCVX)
Nov 5, 2024 04:50PM
Oct 24, 2024 12:03PM
Oct 10, 2024 08:22AM
Sep 10, 2024 06:37AM
Sep 6, 2024 04:06PM
Sep 5, 2024 06:13AM
Sep 4, 2024 05:27AM Vaxcyte (PCVX) PT Raised to $140 at BofA Securities
Sep 3, 2024 04:10PM
Sep 3, 2024 04:02PM
Sep 3, 2024 02:42PM
Sep 3, 2024 11:48AM
Sep 3, 2024 09:34AM
Sep 3, 2024 09:33AM
Sep 3, 2024 08:43AM Vaxcyte (PCVX) Reports Positive Topline Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older
Sep 3, 2024 08:25AM

429,169 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All